v3.26.1
DEFERRED ROYALTY OBLIGATION RELATED TO THE SALE OF FUTURE ROYALTIES - Schedule of Financial Information Related to HCR Agreement (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Non-cash interest expense related to the sale of future royalties $ (1,267) $ (2,219) $ (2,584) $ (4,290)
Deferred Royalty Obligation [Roll Forward]        
Deferred royalty obligation balance as of January 1,     25,876  
Deferred royalty obligation balance as of June 30, 26,317   26,317  
Healthcare royalty partners IV, L.P        
Deferred Royalty Obligation [Roll Forward]        
Deferred royalty obligation balance as of January 1,     25,876 25,527
Non-cash interest expense related to the sale of future royalties     2,584 4,290
Royalty and commercialization milestone payments remitted to HCR     (2,143) (2,056)
Deferred royalty obligation balance as of June 30, $ 26,317 $ 27,761 $ 26,317 $ 27,761
Healthcare royalty partners IV, L.P | Licensing revenue        
Deferred Royalty Obligation [Roll Forward]        
Effective interest rate 19.60% 33.50% 19.60% 33.50%